Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Flexitouch Plus vs Flexitouch Plus With Novel Firmware in Lower Extremity Lymphedema
NCT07613931Phase 1Recruiting
- Sponsor
- Tactile Medical
- Start
- Jul 2026
- Primary completion
- Sep 2026
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial in lower extremity lymphedema (LEL), sponsored by Tactile Medical. Primary endpoints: Lymphatic anatomy at 60 months and Lymphatic propulsion at 60 months. Started Jul 2026; status: recruiting.
02
Conditions
lower extremity lymphedema (LEL)
Beyond the preview
Go deeper on NCT07613931.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07613931.